Labs / Assays & in vitro testing

ADViRNA
Worcester, MA, United States · advirna.com
ADViRNA develops and provides oligonucleotide therapeutics services for researchers in academia, biotech, and pharma. It supports projects from target identification and design through synthesis, screening, biodistribution analysis, and preclinical candidate validation. The company is based in Worcester, Massachusetts.
They take quote requests through a form on their website with project details. Their quote form
What they offer
Strategic Experimental Planning
Expert consultation for design, troubleshooting, and delivery strategies.
Oligonucleotide Design
Targeted design services for siRNAs and ASOs, including sequence prioritization and filtering.
Oligonucleotide Synthesis
Custom synthesis of siRNAs, ASOs, and other oligonucleotides with chemical modifications and conjugation options.
Oligonucleotide Screening
High-throughput screening of siRNAs and ASOs to identify potent candidates and validate knockdown.
Custom Assay Development
Development of assays for molecular and functional readouts such as ELISA, western blotting, cell viability, qPCR, and reporter assays.
HYBRID-ON™ Oligonucleotide Detection Assay
Detection and quantification of modified siRNAs and ASOs in complex biological samples.
Biodistribution Analysis
Tissue detection and biodistribution assessment using the HYBRID-ON platform.
Precision Data Analysis
Scientist-curated data outputs from raw values to publication-ready figures.
In Vivo Study Coordination
Coordination of in vivo study design, synthesis, and downstream sample analysis through a CRO network.
siRNA Reagents
Validated and non-validated siRNA products, including starter kits and custom targets.
What they work on
- Modalities
- Oligonucleotide, mRNA
- Species and models
- human, mouse, rat, rabbit, ocular tissues, primary neurons, cardiomyocytes
- Assays and studies
- qPCR, dual-luciferase psiCHECK reporter, ELISA, Western blotting, cell viability assessment, RNA-seq, biodistribution detection
- Instruments and platforms
- TaqMan, dual-luciferase psiCHECK system
- Scale and capacity
- 1-10 nmol, 10-200 nmol, 0.2-2 umol, 1 to 1000+ candidates, 5 nmol
- Therapeutic areas
- neurological, cardiac, metabolic, oncological, immunological
- Turnaround
- most screens are completed within two weeks of receiving materials
- What to send
- target gene · species · therapeutic modality (siRNA/ASO) · program stage · key constraints or questions
- Type
- CRO
- Sites
- Worcester, United States
- Serves
- global
- Address
- 17 Briden Street, Suite 102 Worcester, MA 01609
- Founded
- 2007
Similar labs. Tetrad DISCOVERY, Alcami, Axela Biosciences, Inc, AxisPharm
Found in a contract services directory. Listing built from advirna.com. Work here? Claim this listing.